Table 1 Outcome for phenotypic marker: gender
From: The clinical use of biomarkers as prognostic factors in Ewing sarcoma
Author | Year | Pt number | P |
|---|---|---|---|
Craft et al, Eur J Cancer 33 (7), 1061-9[8] | 1997 | 142 | 0.3 |
Aparicio et al, Oncology 55, 20-6 [9] | 1998 | 116 | NS |
Ahrens et al, Med Pediatr Oncol 32, 186-95 [10] | 1999 | 177 | 0.92 |
Ginsberg et al, J Clin Oncol 17, 1809-14[11] | 1999 | 85 | 0.79 |
Givens et al, Int J Oncol 14 (6), 1039-43[12] | 1999 | 85 | NS |
Bacci et al, J Clin Oncol 18, 4-11[13] | 2000 | 359 | 0.02 |
Jenkin et al, Med Pediatr Oncol 37, 383-9[14] | 2001 | 93 | 0.73 |
Krasin et al, Cancer 104, 367-73[15] | 2005 | 33 | 0.25 |
Bacci et al, Acta Oncol 45, 469-75[16] | 2006 | 579 | 0.03 |
De Angulo et al, J Pediatr Hematol Oncol 29 (1), 48-52[17] | 2007 | 24 | NS |
Leavey et al, Pediatr Blood Cancer 51 (3), 334-8[18] | 2008 | 262 | 0.05 |
Jawad et al, Cancer 115, 3526-36[19] | 2009 | 1631 | 0.004 |
Kikuta et al, Clin Cancer Res 15 (8), 2885-94[20] | 2009 | 8 | 0.53 |
Sari et al, Pediatr Blood Cancer 54, 19-24[21] | 2010 | 87 | 0.04 |
Xie et al, Chin J Cancer 29 (4), 420-4 | 2010 | 18 | 0.36 |